Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
60.2M
-
Shares change
-
-1.4M
-
Total reported value, excl. options
-
$4.62B
-
Value change
-
+$11.8M
-
Put/Call ratio
-
1.73
-
Number of buys
-
92
-
Number of sells
-
-46
-
Price
-
$76.70
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q1 2019
162 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q1 2019.
Guardant Health, Inc. - Common Stock (GH) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.2M shares
of 124M outstanding shares and own 48.62% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (27.9M shares), SC US (TTGP), LTD. (7.78M shares), VK Services, LLC (7.14M shares), MORGAN STANLEY (1.91M shares), Temasek Holdings (Private) Ltd (1.61M shares), ORBIMED ADVISORS LLC (1.53M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.42M shares), VANGUARD GROUP INC (1.15M shares), BlackRock Inc. (1.13M shares), and FRANKLIN RESOURCES INC (1.04M shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.